Vincent Olorunnisomo
Urology · Joliet, ILNPI 1396064176
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,873 of the $3,450 with a category attached, or 83.3%. 36 manufacturers reported payments, led by Astellas Pharma US Inc at 25.6% of the total. Reporting peaked in 2022 at $869 and has fallen 97.4% since, to $23 in 2024.
Across 149 payments — averaging $23.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$883
- Boston Scientific$339
- Travere Therapeutics, Inc.$246
- AstraZeneca$201
- Olympus America Inc.$129
- Medtronic$122
- plus $2K from 30 others
What the payments were for
- Food & beverage$2,87383%
- Education$51415%
- Other$632%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 36 | $883 |
| Boston Scientific | 8 | $339 |
| Travere Therapeutics, Inc. | 13 | $246 |
| AstraZeneca | 4 | $201 |
| Olympus America Inc. | 4 | $129 |
| Medtronic | 6 | $122 |
| Endo Pharmaceuticals Inc. | 7 | $107 |
| AbbVie(2 entities) | 5 | $103 |
| Bayer | 6 | $96 |
| Myriad Genetic Laboratories, Inc. | 4 | $91 |
| Johnson & Johnson | 4 | $89 |
| Clarus Therapeutics Inc. | 5 | $84 |
| Myovant Sciences Inc. | 4 | $76 |
| Merck | 4 | $71 |
| Coloplast | 4 | $71 |
| Baxter Healthcare | 1 | $63 |
| Tolmar Pharmaceuticals, Inc. | 3 | $60 |
| Axonics, Inc. | 2 | $59 |
| Urovant Sciences Inc | 4 | $59 |
| Agiliti Surgical, Inc. | 1 | $58 |
| Antares Pharma, Inc. | 3 | $56 |
| Pfizer | 3 | $54 |
| 180 Medical, Inc. | 2 | $48 |
| Roche Diagnostics Corporation | 2 | $41 |
| Teleflex LLC | 2 | $38 |
| Dendreon Pharmaceuticals LLC | 1 | $32 |
| Sumitomo Pharma America, Inc. | 2 | $29 |
| Halozyme Inc | 1 | $21 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $20 |
| Sanofi | 1 | $20 |
| Neotract Inc. | 1 | $17 |
| Therapeuticsmd, Inc. | 1 | $15 |
| Telix Pharmaceuticals | 1 | $15 |
| Dentsply IH Inc. | 1 | $13 |
| Procept Biorobotics Corporation | 1 | $12 |
| Zyla Life Sciences, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,450 in reported general payments places this provider in the 55th percentile of 550 urology providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 71 | $1,477 |
| Finasteride | 32 | $632 |
Paid to pharmacies, not to this prescriber.
Other urology in Joliet
- Gregory AndrosJoliet$23K
- Mark BrandtPark Ridge$1.3M
- Aaron BergerChicago Ridge$583K
- Gary SteinbergChicago$529K
- Simone CrivellaroChicago$526K
- Brian HelfandChicago$517K
- Ashley RossChicago$404K
- Kevin McVarySpringfield$372K
- Richard HarrisMelrose Park$363K
- Amy KrambeckChicago$356K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.